Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer

Clinical trial NCT01848067 · COMPLETED

Trial details

NCT number: NCT01848067
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Prostate Hormone-resistant Prostate Cancer Recurrent Prostate Cancer Stage IV Prostate Cancer

Start date: 2013-08-14
Primary completion: 2015-03-03
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.